mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.097 |
0.07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.08 |